Ardea Biosciences, Inc. (NASDAQ: RDEA) is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), gout, cancer and inflammatory diseases. The unique combination of resources and the talents of our integrated research and development organization, coupled with an experienced management team with a track record of pharmaceutical product registrations, position us for future success.

Webcasts

Lazard Capital Markets 5th Annual Healthcare Conference Tuesday, November 18, 2008 4:40 PM ET New York City

20th Annual Piper Jaffray Health Care Conference Tuesday, December 2, 2008 9:00 AM ET New York City

Latest News and Press Releases

To Review All Press Releases click here